Unknown

Dataset Information

0

Synthesis, biological evaluation, and physicochemical property assessment of 4-substituted 2-phenylaminoquinazolines as Mer tyrosine kinase inhibitors.


ABSTRACT: Current results identified 4-substituted 2-phenylaminoquinazoline compounds as novel Mer tyrosine kinase (Mer TK) inhibitors with a new scaffold. Twenty-one 2,4-disubstituted quinazolines (series 4-7) were designed, synthesized, and evaluated against Mer TK and a panel of human tumor cell lines aimed at exploring new Mer TK inhibitors as novel potential antitumor agents. A new lead, 4b, was discovered with a good balance between high potency (IC50 0.68?M) in the Mer TK assay and antiproliferative activity against MV4-11 (GI50 8.54?M), as well as other human tumor cell lines (GI50<20?M), and a desirable druglike property profile with low logP value (2.54) and high aqueous solubility (95.6?g/mL). Molecular modeling elucidated an expected binding mode of 4b with Mer TK and necessary interactions between them, thus supporting the hypothesis that Mer TK might be a biologic target of this kind of new active compound.

SUBMITTER: Wang SB 

PROVIDER: S-EPMC4920374 | biostudies-literature | 2016 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications

Synthesis, biological evaluation, and physicochemical property assessment of 4-substituted 2-phenylaminoquinazolines as Mer tyrosine kinase inhibitors.

Wang Sheng-Biao SB   Cui Mu-Tian MT   Wang Xiao-Feng XF   Ohkoshi Emika E   Goto Masuo M   Yang De-Xuan DX   Li Linna L   Yuan Shoujun S   Morris-Natschke Susan L SL   Lee Kuo-Hsiung KH   Xie Lan L  

Bioorganic & medicinal chemistry 20160517 13


Current results identified 4-substituted 2-phenylaminoquinazoline compounds as novel Mer tyrosine kinase (Mer TK) inhibitors with a new scaffold. Twenty-one 2,4-disubstituted quinazolines (series 4-7) were designed, synthesized, and evaluated against Mer TK and a panel of human tumor cell lines aimed at exploring new Mer TK inhibitors as novel potential antitumor agents. A new lead, 4b, was discovered with a good balance between high potency (IC50 0.68μM) in the Mer TK assay and antiproliferativ  ...[more]

Similar Datasets

| S-EPMC5151143 | biostudies-literature
| S-EPMC10819570 | biostudies-literature
| S-EPMC6071741 | biostudies-literature
| S-EPMC3962266 | biostudies-literature
| S-EPMC4450862 | biostudies-literature
| S-EPMC3980660 | biostudies-literature
| S-EPMC7534383 | biostudies-literature
| S-EPMC6804006 | biostudies-literature
| S-EPMC5850725 | biostudies-literature
| S-EPMC5296338 | biostudies-literature